James is the Managing Partner of TechCXO’s Executive Operations practice, encompassing career CEOs and COOs. With more than three decades of executive leadership across private equity, family-owned, and publicly traded companies, James brings strategic insight, operational discipline, and transaction-savvy expertise to every engagement.
His portfolio at TechCXO spans interim and fractional CEO and COO roles, M&A advisory, and board governance across sectors, including healthcare, life sciences, business services, consumer packaged goods, and high-end luxury goods. James is a go-to partner for companies navigating complexity, whether that’s preparing for a transaction, integrating recent acquisitions, leading on an interim basis, or recalibrating operations for growth.
He also serves as a fractional Operating Partner, supporting lower-middle-market PE and growth firms across the full deal lifecycle. This includes diligence and thesis development, post-close execution, and portfolio optimization across a range of sectors and ownership models.
Recent engagements for TechCXO include:
- Directed a post-merger integration for a $400M PE-owned healthcare payments company.
- Led M&A strategy and company readiness for a $30M family-owned home health provider, including diligence and pipeline development.
- Served as interim CEO for a $30M healthcare staffing company during a critical leadership transition.
- Acted as interim COO for a market leading, family-owned greeting card brand.
- Advised the CEO and Board of a luxury lighting and furniture company.
These engagements reflect a consistent focus on transitional leadership, transaction execution, and strategic advisory across a range of ownership structures.
Across his career, James has led multiple business transformations as CEO, guided strategic direction as a board member, and built enterprise value across both public and PE-backed firms. As CEO and Board Director of EMSI, a PE-owned healthcare services provider, he delivered a full-company transformation; he focused on driving growth in new segments, implementing digital workflows, and restructuring sales for commercial excellence. At Hooper Holmes, a 2,500-employee public company, he executed a turnaround through divestitures, recapitalization, and the creation of a high-growth wellness division.
James’s board experience includes Alcanza Clinical Research, where he supported strategic direction, M&A execution, and performance oversight. At RSA Medical, he partnered with the CEO and founder to navigate post-Affordable Care Act strategy and prepare the company for a successful exit. He has deep experience advising private equity and private credit sponsors, helping companies accelerate value creation through strategy, operational excellence, and leadership alignment.
Earlier in his career, James served in senior roles at GE and Mellon, and started his advisory and M&A work with COBA (part of Bain) and Broadview/Jefferies. His work across strategic planning, integration, and performance improvement gives him a 360-degree view of what it takes for growth-mode and mid-market businesses to scale and succeed.
James earned his MBA with distinction from Harvard Business School and holds a Bachelor and Master of Engineering from Oxford University.
Based in the New York area, he is a trusted advisor to CEOs, boards, and investors. Known for building trust before strategy, he brings calm confidence to complex moments and helps organizations move from strategic intent to execution with clarity and results.